The FDA overstepped its authority, argues Dr. Ben Carson and C. Boyden Gray.
For the first two years of the COVID-19 pandemic, there were few — if any — recommendations from federal public health authorities for treatments prior to hospitalization. The issue of early treatment is critical in any discipline of medicine, and no less so here. But early treatment of COVID-19 was dismissed by the medical establishment.
If there be any doubt about the vital importance of early treatment, consider the directions from Pfizer about Paxlovid. The company insists , and the FDA now parrots , the drug should be administered as soon as possible after a COVID-19 diagnosis, and at least within 5 days of symptom onset.
While existing clinical examination has demonstrated sufficient efficacy for an emergency use authorization from the FDA, the fact remains that Paxlovid has yet to receive full approval from the agency. Recently reports […]
Excerpt Sourced From: stream.org
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
